Statistics

Total Visits

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)11

Select a period of time:

Number of views in the range

Views
Tenofovir DF prevents HBV reactivation in anti-HBc positive patients with hematologic malignancies treated with Rituximab: 12-months results of a randomized study (PREBLIN study)5

Views

Views
November 20230
December 20230
January 20241
February 20241
March 20241
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn1
Boardman1